8 Liver Cirrhosis (Hepatic Cirrhosis) Nursing Care Plans

Cirrhosis is the end of the road for a liver that has been injured long enough. Scar tissue replaces functioning hepatic cells, blood and lymph flow back up, and the organ slowly fails. On the floor your patient shows up with some mix of ascites, jaundice, bleeding risk, and a brain that is starting to fog over from rising ammonia. Your job is to manage those four problems at once: keep fluid and sodium under control, protect the skin and the airway, prevent variceal bleeds, and catch encephalopathy before it becomes coma.

What is Liver Cirrhosis?

Liver cirrhosis (hepatic cirrhosis) is chronic, diffuse destruction of hepatic cells with fibrotic regeneration. Viral infection, toxins, hereditary conditions, and autoimmune processes all injure the liver. Each injury lays down scar tissue. Early on, function holds. After long-standing injury most of the tissue fibroses, function is lost, and cirrhosis develops. Fibrosis distorts the liver's structure and vasculature, impairs blood and lymph flow, and ends in hepatic insufficiency.

Chronic liver disease usually progresses to cirrhosis. The most common causes in the United States are hepatitis C, alcoholic liver disease, cryptogenic causes, hepatitis B, and miscellaneous causes (autoimmune hepatitis, primary biliary cholangitis, Wilson disease). Cirrhosis is the 9th leading cause of death in the United States and the 14th most common cause of death worldwide. In Europe it is the 4th.

Clinical types of cirrhosis:

• Laennec's cirrhosis is the most common type, occurring in 30% to 50% of cirrhotic patients. Up to 90% have a history of alcoholism. Damage results from malnutrition (especially dietary protein) and chronic alcohol intake; fibrous tissue forms in portal areas and around central veins.
• Biliary cirrhosis occurs in 15% to 20% of patients and results from injury or prolonged obstruction.
• Postnecrotic cirrhosis stems from hepatitis.
• Pigment cirrhosis results from disorders such as hemochromatosis.
• Idiopathic cirrhosis has no known cause.
• Noncirrhotic fibrosis may result from schistosomiasis, congenital hepatic fibrosis, or idiopathic causes.

Presentation runs the full range. Some patients are asymptomatic with a near-normal life expectancy; others carry every sign of end-stage disease with little chance of survival. Common findings include hepatomegaly, abdominal pain, ascites, abdominal distention, bulging flanks, shifting dullness, anorexia, weight loss, fatigue, and muscle wasting. Cutaneous signs include jaundice, spider angiomata, skin telangiectasia ("paper money skin"), palmar erythema, white nails, loss of lunulae, and finger clubbing.

Nursing Care Plans and Management

The goals are to manage ascites, jaundice, and encephalopathy, reduce injury risk, prevent and treat portal hypertension and variceal bleeding, and build self-care. Nursing work centers on nutrition, fluid balance, and the patient's emotional load.

Nursing Problem Priorities

• Monitor and support liver function.
• Address complications such as portal hypertension and ascites.
• Manage symptoms and protect quality of life.
• Teach dietary modification and fluid restriction when needed.
• Give medications to control symptoms and slow progression.
• Watch for and manage hepatic encephalopathy and variceal bleeding.
• Support lifestyle changes, including alcohol cessation and weight management.

Nursing Assessment

Assess for the following subjective and objective data:

• Fatigue and weakness
• Abdominal pain or discomfort
• Ascites (distension, shifting dullness on percussion)
• Nausea, vomiting, or appetite change
• History of alcohol abuse
• Jaundice
• Pruritus
• Weight loss or weight change
• Coagulation problems or easy bruising
• Hepatic encephalopathy signs (altered mental status, confusion, asterixis)
• Spider angiomas or palmar erythema
• Elevated liver enzymes (ALT, AST), bilirubin, and INR

Nursing Diagnosis

Form your nursing diagnosis from assessment findings and clinical judgment, tied to the patient's specific picture. The label matters less than the reasoning behind it. Prioritize the patient's actual problems and adjust as the picture changes.

Nursing Goals

Goals and expected outcomes may include:

• The patient demonstrates progressive weight gain toward goal with normalization of lab values.
• The patient shows no further signs of malnutrition.
• The patient maintains stable fluid volume: balanced I&O, stable weight, vital signs within normal range, and no edema.
• The patient maintains skin integrity.
• The patient reports reduced itching or tolerates it without scratching.
• The patient identifies risk factors and demonstrates techniques to prevent skin breakdown.
• The patient maintains an effective respiratory pattern, free of dyspnea and cyanosis, with ABGs and vital capacity within acceptable range.
• The patient maintains homeostasis without bleeding and demonstrates behaviors to reduce bleeding risk.
• The patient maintains usual mentation and reality orientation.
• The patient initiates lifestyle changes to prevent recurrence.
• The patient verbalizes understanding of the disease process, prognosis, and potential complications and participates in care.

Nursing Interventions and Actions

1. Enhancing Nutritional Balance

Malnutrition tracks cirrhosis from compensated disease through liver failure, and catching it early is half the battle. With the rise of obesity, diabetes, and non-alcoholic fatty liver disease (NAFLD), you also see the opposite problem: adiposity layered over muscle loss, called sarcopenic obesity, which makes nutrition planning harder.

Evaluate the patient for malnutrition. 80 to 90% of the blood leaving the stomach and intestines carries nutrients to the liver for conversion. A failing liver means malnutrition from poor intake, malabsorption, anorexia, nausea, vomiting, or early satiety from ascites. Decreased bile secretion also impairs absorption of fat and the fat-soluble vitamins A, D, E, and K.

Determine interest in eating and ability to chew, swallow, and taste. These drive intake. Massive ascites compresses the GI tract, depressing appetite.

Use validated nutritional screening tools. Screen every patient regardless of BMI. Options include the Malnutrition Universal Screening Tool (MUST) and Nutritional Risk Screening-2002.

Assess functional status. Watch them walk in. Gauge handshake strength, the ability to rise from a chair, exercise tolerance, and ADL performance. Validated measures include the short physical performance battery, incremental shuttle walk test, and the liver frailty index (hand grip strength, timed chair stands, balance).

Measure dietary intake by calorie count. A patient with cirrhosis needs a balanced protein diet of 2,000 to 3,000 calories per day to permit liver cell regeneration. For compensated cirrhosis, target 25 to 35 kcal/kg/day of energy and 1.2 to 1.5 g/kg/day of protein to hold muscle mass. For decompensated cirrhosis with sarcopenia, target 30 to 35 kcal/kg/day and 1.5 to 2.0 g/kg/day to reverse it.

Weigh and compare against fluid status and skinfold measures. Edema and ascites make raw weight unreliable. Skinfold measurements track muscle mass and subcutaneous fat. Record dry weight and BMI: weigh after paracentesis, or estimate by subtracting for ascites (mild 5%, moderate 10%, severe 15%) and peripheral edema (5% if bilateral).

Perform anthropometry as indicated. Mid-arm muscle circumference (MAMC) and hand grip strength both predict mortality. Test hand grip three times in the non-dominant hand and compare with normal values: 29 kg for women, 40 kg for men.

Assess severity of cirrhosis. The Child-Turcotte-Pugh (CTP) score predicts life expectancy in advanced disease; a CTP of 10 or greater carries a 50% chance of death within 1 year. Since 2002, US transplant programs have used the Model for End-stage Liver Disease (MELD) score to grade severity.

Monitor serum glucose, prealbumin, albumin, total protein, prothrombin time (PT), and ammonia. See Laboratory and Diagnostic Procedures.

Review glycemic control. Check HbA1c, especially with diabetes and anti-diabetic medications, but read it in context, since anemia can make it falsely reassuring.

Encourage eating and involve the family. Explain the diet. Feed the patient if they tire easily or have a caregiver assist. Include the patient in meal planning. Push a regular pattern of meals and snacks every 2 to 3 hours, including a bedtime snack, to cut starvation time and limit breakdown of muscle and fat for fuel.

Encourage all meals plus supplementary feedings. Anorexia, weakness, and nausea make patients pick at food. Aggressive treatment of protein-calorie malnutrition is standard in alcoholic cirrhosis, with multiple feedings per day including breakfast and a night snack.

Give small, frequent meals. Larger meals are poorly tolerated with ascites and raised intra-abdominal pressure. Divided meals and late-evening snacks (rice balls, liquid nutrients, branch chain amino acid supplements) help; pull roughly 200 kcal from the daily total as a bedtime snack to cover overnight starvation.

Provide salt substitutes if allowed, but avoid those containing ammonium. Ammonia raises encephalopathy risk. Salt restriction is first-line: most patients start below 2000 mg sodium daily, and refractory ascites may require below 500 mg daily. Do not push restriction so far that you create calorie-protein malnutrition.

Restrict alcohol, raw or uncooked food, and excessively fatty foods. Any alcohol is unsafe in cirrhosis and drives more damage. A damaged liver cannot process high-fat meals well. Impaired immune function makes raw or undercooked food a real infection risk.

Encourage frequent mouth care, especially before meals. Sore or bleeding gums and a bad taste worsen anorexia. Fetor hepaticus, a sweet, musty, sometimes fecal breath, comes from portosystemic shunting in portal hypertension.

Promote undisturbed rest before meals. Conserving energy lowers metabolic demand on the liver and supports cell regeneration. Even with reduced activity, total energy expenditure in cirrhosis runs 28 to 37.5 kcal/kg/day.

Push smoking cessation. Smoking harms the liver through toxic, immunologic, and oncogenic mechanisms and worsens a range of liver diseases.

Maintain NPO status when indicated. Acutely ill patients may need GI rest to cut ammonia and urea production, with nutrition supplied enterally or parenterally. Avoid prolonged fasting: advance the diet early and place an NG tube for enteral feeding at intubation when needed.

Refer to a dietitian for a high-calorie, simple-carbohydrate, low-fat, moderate-to-high-protein diet; limit sodium and fluid as needed. Carbohydrates supply ready energy. Fats are poorly absorbed and cause discomfort. Protein raises serum protein, reduces edema, and supports regeneration, but restrict protein and high-ammonia foods (gelatin) if ammonia is elevated or encephalopathy is present. Vegetable protein is often tolerated better than meat protein.

Provide tube feedings, TPN, and lipids if indicated. Use these when nausea, anorexia, or varices block oral intake. Place a naso- or orogastric tube right after intubation in patients without GI bleeding. Reserve parenteral feeding for when enteral feeding cannot meet energy needs or is contraindicated.

Optimize protein intake. Total body protein breakdown is up and muscle synthesis is down. Recommend 3 to 4 high-protein sources daily, including eggs and lean meat.

Provide oral supplements as prescribed. Sarcopenic patients often need low-volume, high-protein sip feeds. A daily multivitamin is reasonable (without manganese, since elevated levels may worsen encephalopathy), plus individual vitamin and mineral correction when malnourished.

Encourage physical activity as tolerated. Tailor it. A structured program of warm-up, aerobic and resistance work, and cool-down at moderate intensity (the patient can still speak a two- to three-word sentence) supports muscle mass and strength.

Provide oral branch chain amino acid (BCAA) preparations as indicated. See Pharmacologic Management.

2. Managing Ascites and Fluid Volume

Ascites is fluid pooling in the peritoneal cavity. In cirrhosis it comes from sodium and water retention, impaired free-water excretion, and intravascular overload, driven largely by raised renin and aldosterone, and it can happen even with a normal GFR.

Assess respiratory status; note rising rate and dyspnea. These signal pulmonary congestion. Cirrhosis also brings hepatopulmonary syndrome, portopulmonary hypertension, hepatic hydrothorax, low oxygen saturation, and ventilation-perfusion mismatch.

Auscultate lungs for diminished or adventitious sounds. Pulmonary congestion can progress to consolidation and impaired gas exchange. Hepatopulmonary syndrome (HPS) often presents with dyspnea, orthopnea, platypnea, and cyanosis. Platypnea is shortness of breath that worsens sitting or standing and eases lying down.

Monitor BP (and CVP if available); note JVD and abdominal vein distension. BP often rises with volume excess but may not if fluid shifts out of the vascular space. Distended jugular and abdominal veins reflect vascular congestion. Portal hypertension comes from increased portal inflow plus increased resistance to portal flow.

Watch for dysrhythmias; auscultate for an S3/S4 gallop. These point to heart failure, poor coronary perfusion, or electrolyte imbalance. An accentuated split second heart sound, right ventricular heave, right-sided S3 gallop, JVD, and leg edema suggest portopulmonary hypertension.

Assess for ascites. It takes about 1500 ml of fluid to detect ascites reliably on exam, and obesity reduces accuracy. Look for shifting dullness, fluid wave, and puddle signs; shifting dullness has 83% sensitivity and 56% specificity.

Assess peripheral edema. Sodium and water retention, low albumin, and raised ADH push fluid into tissue. Portal congestion raises capillary permeability while low albumin drops plasma oncotic pressure.

Measure I&O, weigh daily, and flag a gain over 0.5 kg/day. This tracks circulating volume and response to therapy. Positive balance usually means continuing retention. Falling circulating volume can hit renal function and lead to hepatorenal syndrome.

Measure abdominal girth. It reflects peritoneal fluid accumulation and helps estimate ascitic and dry weight, especially when paracentesis is not possible.

Monitor serum albumin and electrolytes, especially potassium and sodium. Low albumin drops colloid osmotic pressure and drives edema. Reduced renal blood flow, raised ADH and aldosterone, and diuretics shift electrolytes. A serum-ascites albumin gradient of 1.1 g/dL or greater predicts portal hypertension with 97% accuracy.

Monitor serial chest x-rays and imaging. Vascular congestion, pulmonary edema, and pleural effusions are common, and the diaphragm may be elevated. CT of the thorax rules out mediastinal, pulmonary, or pleural malignancy; Doppler sonography of the abdomen complements it.

Encourage bed rest when ascites is present. It may promote recumbency-induced diuresis. Evidence is not strong enough to require it for everyone.

Restrict sodium and fluids as indicated; keep calories and protein adequate. Restrict sodium to limit extravascular retention; restrict fluid to correct dilutional hyponatremia. Guidelines suggest moderate salt restriction (2 g per day) with energy of 35 kcal/kg/day and protein of 1.2 to 1.5 g/kg/day to avoid malnutrition.

Administer salt-free albumin or plasma expanders as indicated. Albumin raises colloid osmotic pressure, pulls fluid into the vascular space, and cuts ascites formation. Long-term albumin improves effective blood volume, prevents renal dysfunction, supports cardiac inotropism, and reduces inflammation.

Administer diuretics, inotropics, and V2 receptor antagonists as indicated. See Pharmacologic Management.

Prepare for large-volume paracentesis as indicated. Massive ascites may need large-volume paracentesis for relief from abdominal discomfort, anorexia, or dyspnea, and it lowers umbilical hernia rupture risk. It is considered safe in patients with peripheral edema and those not on diuretics.

Assist with peritoneovenous shunts. LeVeen and Denver shunts return ascitic fluid and protein to the intravascular space through subcutaneous tubing connecting the peritoneal cavity to the internal jugular or subclavian vein via a pumping chamber.

Prepare for transjugular intrahepatic portosystemic shunt (TIPS) as indicated. TIPS lowers sinusoidal pressure, plasma renin, and aldosterone, improving urinary sodium excretion. It outperforms large-volume paracentesis for controlling ascites.

Teach which medications to avoid. Avoid or use caution with NSAIDs (sodium retention, hyponatremia, renal failure) and metamizole (acute kidney injury). Avoid ACE inhibitors, angiotensin II antagonists, and alpha-1 blockers because of renal impairment risk.

3. Providing Skin Care and Promoting Skin Integrity

Skin changes in cirrhosis are not specific, but read alongside systemic signs they point to the liver. Catching cutaneous features early can delay complications and cut morbidity and mortality.

Inspect pressure points and skin surfaces routinely. Edematous tissue breaks down easily, and severe ascites can stretch skin to the point of tearing. Assess edema for pitting, tenderness, and skin changes.

Assess for jaundice, itching, and scratching. When the liver cannot excrete bilirubin, it accumulates in skin and sclera, diffuses into tissue, triggers histamine release, and itches. Scratching breaks the skin.

Massage bony prominences gently; use emollient lotions and limit soap. Subcutaneous edema, immobility, jaundice, and infection risk all threaten the skin. Lotion soothes; avoid irritating soaps and adhesive tape.

Reposition on a schedule and assist with ROM exercises. Repositioning offloads edematous tissue and improves circulation; exercise maintains joint mobility.

Elevate lower extremities and use compression stockings. Elevating the legs above heart level for 30 minutes three or four times a day improves edema. Moderate to severe edema needs prescription compression stockings, which apply the most pressure at the ankle and decrease up the leg.

Keep linens dry and wrinkle-free. Moisture worsens pruritus and breakdown; a smooth, dry surface reduces friction and irritation.

Clip fingernails short; provide mittens or gloves if needed. Long nails injure the skin during scratching, especially in sleep.

Provide perineal care after urination and bowel movements. Bile salts excoriate skin. Clean with mild soap and water and apply a barrier cream to prevent breakdown and infection.

Use pressure-relieving surfaces as indicated. Alternating-pressure mattresses, egg-crate mattresses, waterbeds, sheepskins, and silicone mattresses lower dermal pressure, improve circulation, and reduce tissue ischemia. A silicone mattress molds to the body and spreads load evenly over bony prominences, cutting pressure, shear, and friction.

Administer cholestyramine, ursodeoxycholic acid, rifampicin, and SSRIs as indicated. See Pharmacologic Management.

Apply topical antipruritics such as ammonium lactate cream as indicated. See Pharmacologic Management.

Prepare the patient for narrowband ultraviolet B (nbUVB) therapy. nbUVB treats itch and inflammatory skin disorders, likely by altering cytokine release, depleting Langerhans cells, and reducing skin sensitivity to pruritogens.

4. Improving Breathing Pattern and Preventing Respiratory Complications

Pulmonary complications hit with or without decompensation, and you have to separate them from primary lung disease like COPD. The cirrhosis-specific ones are hepatic hydrothorax, spontaneous pulmonary empyema, hepatopulmonary syndrome, and portopulmonary hypertension.

Monitor respiratory rate, depth, and effort. Rapid shallow breathing or dyspnea points to hypoxia or abdominal fluid. Classic HPS shows platypnea and orthodeoxia (arterial oxygen tension drops moving from supine to upright).

Auscultate breath sounds for crackles, wheezes, and rhonchi. Adventitious sounds suggest fluid or secretions; absent or diminished sounds suggest atelectasis. Hepatic hydrothorax can occur without ascites, and tension hydrothorax with cardiac failure has been described.

Investigate changes in level of consciousness. Mental status change may reflect hypoxemia and respiratory failure that accompany hepatic coma. Mild to moderate encephalopathy shows decreased short-term memory and concentration.

Monitor temperature; note chills, increased coughing, and sputum changes. These signal infection, especially pneumonia. Spontaneous bacterial empyema complicates hepatic hydrothorax, with fever as the cardinal sign in decompensated cirrhosis.

Monitor serial ABGs, pulse oximetry, vital capacity, and chest x-rays. See Laboratory and Diagnostic Procedures.

Monitor renal function studies. See Laboratory and Diagnostic Procedures.

Keep the head of bed elevated and position on the sides. This eases breathing by offloading the diaphragm and lowers aspiration risk. For dyspnea or orthopnea, use semi-Fowler or high-Fowler to improve gas exchange against ascitic pressure.

Encourage repositioning, deep breathing, and coughing. These expand the alveoli and mobilize secretions, preventing pooling that leads to infection.

Provide supplemental O2 as indicated. Treat or prevent hypoxia; mechanical ventilation may be needed if oxygenation is inadequate. Evaluate mild to moderate HPS every 3 to 6 months with ABG. Provide supplemental oxygen for saturation below 89% or PaO2 below 55 mm Hg at rest, with exercise, or asleep.

Demonstrate and assist with incentive spirometry or pulmonary function tests. These reduce atelectasis and mobilize secretions. Pulmonary function testing rules out intrinsic lung disease and may show decreased carbon monoxide diffusion capacity.

Prepare for contrast-enhanced echocardiography. See Laboratory and Diagnostic Procedures.

Prepare for and assist with acute care procedures:

• Paracentesis removes ascitic fluid to relieve abdominal pressure when other measures fail to correct respiratory compromise. It is safe in patients with peripheral edema and those not on diuretics; 5 to 15 liters can be removed safely at one time.
• Peritoneovenous shunt surgically returns abdominal fluid to systemic circulation via the vena cava for long-term ascites relief. Reserve it as a last resort for refractory ascites in patients who are not candidates for TIPS or transplant.
• TIPS manages massive ascites by lowering sinusoidal pressure, plasma renin, and aldosterone, but it can worsen pre-existing encephalopathy and liver dysfunction in severe underlying failure.
• Liver transplantation should be considered before intractable liver failure or hepatorenal syndrome; massive ascites carries a 1-year survival rate of less than 50%.

Discuss adding garlic to the diet. Garlic's allicin is a vasodilator and shows improved gas exchange in small studies, though large trials are still needed.

5. Promoting Safety and Preventing Injury

Fibrosis blocks blood flow through the liver, so blood shunts from high-pressure portal vessels into lower-pressure ones. That builds collaterals in the esophagus, stomach, and lower rectum, where they become varices or hemorrhoids. These vessels were never built for that pressure, and when they rupture the patient can exsanguinate fast.

Assess for GI bleeding: check all secretions for frank or occult blood; observe stool, NG drainage, and vomitus. The esophagus and rectum bleed most often because of mucosal fragility and altered hemostasis.

Observe for petechiae, ecchymosis, and bleeding from multiple sites. Subacute disseminated intravascular coagulation (DIC) can develop from altered clotting factors. Bruising, melena, and hematemesis signal bleeding; altered vitals, irritability, air hunger, pallor, and weakness signal significant blood loss and demand prompt action.

Monitor pulse and BP (and CVP if available). A rising pulse with falling BP and CVP means loss of circulating volume. In one series, 43% of patients showed vital instability with hypotension and tachycardia on admission.

Note changes in mentation and LOC. These may reflect decreased cerebral perfusion from hypovolemia and hypoxemia. Variceal bleeding cuts oxygen delivery to the brain, causing confusion and altered mental status.

Monitor hemoglobin, hematocrit, and clotting factors. These flag anemia, active bleeding, or impending complications. Hypersplenism in portal hypertension can cause pancytopenia, and coagulation is impaired.

Avoid rectal temperatures; be gentle with GI tube insertion. Rectal and esophageal vessels rupture easily. Avoid injections when clotting is altered. Thrombocytopenia from splenic consumption and reduced production raises bleeding risk, particularly with counts below 50,000 and with varices.

Encourage a soft toothbrush and electric razor; avoid straining at stool and vigorous nose blowing. With clotting disturbances, minimal trauma causes mucosal bleeding, and raised intra-abdominal or intrathoracic pressure can trigger a bleed.

Use small needles and apply pressure longer than usual to venipuncture sites. Smaller gauge needles minimize trauma. Hold pressure for several minutes, and choose an alternate site if there is bruising or bleeding.

Advise avoiding aspirin-containing products. Aspirin prolongs coagulation and raises overall GI bleeding risk by 60%.

Administer vitamins, stool softeners, vasoconstrictors, vasodilators, antifibrinolytics, and thrombopoietin agonists as indicated. See Pharmacologic Management.

Provide gastric lavage at room temperature or with cool saline as indicated. In acute bleeding, clearing blood from the GI tract cuts ammonia production and encephalopathy risk, and NG lavage shortens time to endoscopy.

Assist with insertion and maintenance of a GI tube. This temporarily controls variceal bleeding when lavage and hemodynamic stabilization fail. NG lavage clears particulate matter, blood, and clots to facilitate endoscopy.

Prepare for surgical procedures: band ligation, esophagogastric resection, or splenorenal-portocaval anastomosis. These control active bleeding or lower portal pressure to prevent recurrence. Obtain surgical and interventional radiology consults before endoscopy when persistent or recurrent bleeding is likely.

Teach the patient to avoid foods that irritate the esophagus. Rough, spicy, or hot foods, hot liquids, and alcohol can injure the esophagus and trigger a bleed. Avoid taco shells, tortilla chips, hard vegetables like carrot sticks, and large pieces of raw fruit. Five to six small meals a day limit irritation.

Encourage vitamin K-rich foods such as spinach, cabbage, cauliflower, and liver. Vitamin K supports clotting and counteracts warfarin, helping reduce bleeding risk.

Administer blood and blood products as prescribed. With severe anemia and uremia, raising the hematocrit by more than 25% improves platelet margination and hemostasis; each unit of red cells runs about 250 mL. Platelets pooled from five to six donors or single-donor apheresis raise the count by 5,000 to 10,000. Off-label prothrombin complex corrects vitamin K-dependent factor deficiencies.

6. Preventing Hepatic Encephalopathy

Hepatic encephalopathy brings personality change, intellectual impairment, and a falling level of consciousness. Diverting portal blood into systemic circulation appears to be the setup, with altered brain energy metabolism and a leakier blood-brain barrier that lets neurotoxins through.

Observe for behavioral and mental changes: lethargy, confusion, drowsiness, slurred speech, irritability. Ongoing assessment matters because impending coma fluctuates. Mild to moderate encephalopathy shows reduced short-term memory and concentration.

Review the medication regimen for adverse reactions. Drug reactions and interactions (such as cimetidine plus antacids) can worsen confusion. Cimetidine confusion shows up in older adults and in renal or hepatic failure, and cimetidine delays clearance of benzodiazepines.

Evaluate sleep and rest. Sleep loss worsens cognition and lethargy. Sleep disturbance is common in cirrhosis; hydroxyzine can help but may worsen encephalopathy in some patients.

Note asterixis, fetor hepaticus, and seizure activity. These suggest rising serum ammonia and progression to encephalopathy. Asterixis also appears in uremia, pulmonary insufficiency, and barbiturate toxicity, and portosystemic shunting can cause extrapyramidal signs.

Get a baseline from caregivers and chart personality, LOC, and orientation. Family notices slight personality and behavior changes first, and a baseline lets you catch progression toward coma.

Investigate temperature elevations and monitor for infection. Infection precipitates encephalopathy through tissue catabolism, nitrogen release, and impaired renal function, all of which raise blood ammonia.

Use testing tools to identify encephalopathy. Minimal and covert encephalopathy matter for quality of life and counseling. The Portosystemic Encephalopathy (PSE) Syndrome Test uses five paper-pencil tests of cognitive and psychomotor speed. The Continuous Reaction Times (CRT) test measures motor reaction time to auditory stimuli and is not affected by age or gender.

Have the patient write their name periodically and do simple arithmetic; keep the records. Deteriorating handwriting signals worsening encephalopathy. Disorientation and asterixis mark grade 2 encephalopathy.

Reorient to time, place, and person as needed. This reduces confusion and anxiety and reconnects the patient to their surroundings.

Keep the environment quiet; approach calmly and protect rest periods. This cuts overstimulation, promotes relaxation, lowers demand on the liver, and increases hepatic blood supply. Advance activity gradually once nutrition and strength improve.

Provide continuity of care; assign the same nurse when possible. Familiarity reassures the patient, lowers anxiety, and improves documentation of subtle changes.

Reduce provocative stimuli and confrontation; do not force activities. This prevents agitated responses and protects safety. Even with minimal encephalopathy, patients show impaired sustained attention and delayed reaction time.

Discuss the current situation and what to expect. Intellectual and emotional function may improve as liver involvement resolves, and clear information gives the patient back a sense of control.

Maintain bed rest and assist with self-care. This lowers metabolic demand, prevents fatigue, and limits ammonia buildup. Success depends on full adherence: rest, lifestyle change, adequate intake, and no alcohol.

Provide for safety: assist with ambulation, keep the bed low, raise and pad side rails as needed. Confusion, seizures, or violent behavior raise injury risk, and reorientation supports safety. A patient in alcohol withdrawal is also at seizure risk.

Avoid narcotics, sedatives, and anti-anxiety agents; limit drugs metabolized by the liver. Some drugs are hepatotoxic; others accumulate because the cirrhotic liver cannot clear them, masking or precipitating encephalopathy. Avoid CNS depressants, especially benzodiazepines. Severe agitation with encephalopathy may be managed with haloperidol.

Eliminate or restrict dietary protein; provide glucose supplements and hydration. Ammonia from protein breakdown drives the mental changes. Glucose spares protein catabolism. Restrict protein only right after a severe flare; it is rarely justified long-term, and patients with mild chronic encephalopathy tolerate more than 60 to 80 g of protein per day.

Favor vegetable protein over meat protein. Vegetable protein is better tolerated, likely from higher fiber (a natural cathartic) and lower aromatic amino acids, which worsen encephalopathy.

Administer cathartics, antibiotics, zinc, and L-ornithine L-aspartate (LOLA) as indicated. See Pharmacologic Management.

7. Promoting Positive Self Body Image

Cirrhosis hits quality of life hard, and disease severity tracks with the damage. Gross ascites brings abdominal discomfort, breathlessness, stress, anxiety about body image, immobility, and a higher fall risk.

Discuss the situation and encourage the patient to voice fears and concerns. Patients are sensitive to body changes and may feel guilt when the cause is alcohol or drug use. Frequent procedures, more pills, and dietary restriction all weigh on quality of life.

Assess changes in appearance and what they mean to the patient and family. This gauges the impact on body image, sexual function, and role. Patients with cirrhosis face anxiety, reduced social interaction, regret, and strained relationships.

Assess prior coping strategies. Reinforce what has worked before. Active problem-solving is common, and demographic factors do not strongly predict coping style.

Support the patient with a positive, nonjudgmental attitude. Patients with alcohol- or hepatitis-related cirrhosis report prejudice from providers. Do not let judgment affect care; help the patient feel valued.

Encourage family to express feelings, visit freely, and join in care. Family may feel guilt and fear of impending death and need nonjudgmental support and access. Participation builds trust and helps them feel useful. Support persons are key to practical help and to getting patients to seek care.

Help the patient cope with appearance changes; suggest clothing that does not emphasize them. Jaundice, ascites, and ecchymoses change appearance. Support protects self-esteem and a sense of control.

Refer to support services, counselors, social services, clergy, and alcohol treatment. This illness raises vulnerability that often needs added professional support. Liver specialist nurses are especially important to self-management.

Help the patient set short-term goals and include them in care planning. Meeting goals reinforces effort and builds self-esteem.

Provide accurate, current information about the condition. Tailored, visual resources help patients with low health literacy and return a sense of control.

Build rapport through therapeutic communication. Poor communication undermines outcomes in chronic disease. Create a safe environment, allow time to build rapport, and use a support person when helpful.

Help the patient identify past self-harmful practices such as alcohol and drug abuse. Acknowledging the harm is necessary to change. For some, a cirrhosis diagnosis brings relief or reassurance, and inner strength can drive alcohol abstinence.

8. Initiating Patient Education and Health Teaching

Cirrhosis reshapes the patient's life and reaches their family. Education is how they control the disease and limit complications. Chronic disease management works better when patients have the knowledge to manage their own health.

Review the disease process, prognosis, and what to expect. This builds the base for informed choices. Health literacy is the capacity to obtain, process, and understand health information well enough to make decisions.

Identify environmental dangers such as hepatitis exposure. These can trigger recurrence. Hepatitis C is now the leading cause of chronic hepatitis and cirrhosis in the United States.

Assess the patient's knowledge of the disease and treatment. What they understand shapes how they experience treatment.

Assess the patient's anxiety level. The stress of diagnosis is a window for behavior change; high anxiety often makes patients more eager to absorb information and change their lifestyle, so early teaching pays off.

Refer to a dietitian or nutritionist. Dietary education is central at discharge, above all excluding alcohol. Consider referral to Alcoholics Anonymous, psychiatric care, or counseling.

Stress avoiding alcohol; give information on rehabilitation resources. Alcohol is the leading driver of cirrhosis. Cessation counseling helps, though some patients find group settings overwhelming or find it was never offered.

Inform the patient that cirrhosis alters drug effects; use only medications cleared by a provider who knows their history. Narcotics, sedatives, and hypnotics are hepatotoxic, and the damaged liver clears all drugs poorly, raising cumulative effects and bleeding tendencies. New therapy warrants more frequent liver chemistries.

Review how to maintain a peritoneovenous shunt. A Denver shunt requires the patient to pump the chamber periodically for patency. A LeVeen shunt may need an abdominal binder or Valsalva maneuver. Both return ascitic fluid and protein through subcutaneous tubing to the internal jugular or subclavian vein via a pumping chamber.

Help the patient identify support persons. Recovery is slow with frequent relapses, so support systems are essential to maintaining behavior change.

Emphasize good nutrition; advise avoiding high-protein, salty foods, onions, and strong cheeses; provide written instructions. Limiting sodium and protein eases symptoms and prevents ammonia buildup. Without ascites, edema, or impending coma, the patient should get a nutritious, high-protein diet as tolerated, supplemented with B-complex and vitamins A, C, and K, with sodium restriction to prevent ascites.

Stress the necessity of followup and adherence. The disease is chronic with life-threatening potential, and followup evaluates the regimen, including shunt patency. Success depends on full adherence to rest, lifestyle change, adequate intake, and no alcohol.

Discuss sodium and salt-substitute limits and reading labels on food and OTC drugs. This minimizes ascites and edema. Overusing substitutes causes other electrolyte imbalances. Antacids and some mouthwashes contain sodium or alcohol.

Encourage activity with adequate rest periods. Rest cuts metabolic demand and frees energy for tissue regeneration. Because the patient is at risk from immobility, prevent atelectasis, pneumonia, venous thromboembolism, and pressure injuries.

Promote enjoyable diversional activities. These prevent boredom and ease anxiety and depression, which affect medication adherence, self-care, and alcohol use.

Advise avoiding people with infections, especially URIs. Decreased resistance, poor nutrition, and leukopenia from splenomegaly raise infection risk. Patients with cirrhosis carry a two- to three-fold higher risk of bacterial infection and sepsis, and 32 to 40% of hospitalized patients develop bacterial infections.

Teach the warning signs that warrant calling the provider: increased abdominal girth; rapid weight loss or gain; increased peripheral edema; increased dyspnea; fever; blood in stool or urine; excess bleeding; jaundice. Prompt reporting heads off further hepatic damage and life-threatening complications. Bleeding risk is high from decreased prothrombin production and impaired synthesis of clotting factors.

Teach caregivers to report confusion, untidiness, night wandering, tremors, or personality changes. These deterioration signs are often clearer to family. Monitoring catches early progression through the four stages of encephalopathy.

Prepare the patient and caregiver for transitional care. Referral for transitional or home care eases the move from hospital to home, where the nurse reinforces teaching and answers new questions about eating, drinking, and lifestyle.

Support the patient and family through recovery. Recovery is slow with frequent setbacks, and many patients struggle to stay off alcohol. Offer encouragement and positive feedback on success.

Maintain effective communication with the patient and family. A positive patient-caregiver relationship raises commitment to treatment and patient participation in care.

Provide information about religious services the patient and family can use. Religious belief can help patients confront illness, create hope, and tolerate their condition.

9. Administer Medications and Provide Pharmacologic Support

Medications target the underlying disease, prevent complications, and ease symptoms: diuretics such as spironolactone and furosemide for ascites and edema, lactulose or rifaximin for encephalopathy, beta-blockers such as propranolol or nadolol to cut variceal bleeding, and ursodeoxycholic acid to support bile flow and protect hepatocytes.

Oral branch chain amino acid (BCAA) preparations. BCAA preparations improve hypoalbuminemia and amino acid imbalance. BCAA granules maintain or raise serum albumin in decompensated cirrhosis, prevent adverse events, and improve prognosis and quality of life; match the preparation to the patient's malnutrition state and encephalopathy status.

Diuretics such as spironolactone and furosemide. Use with caution to control edema and ascites by blocking aldosterone and raising water excretion while sparing potassium, when bed rest and sodium restriction are not enough. Aggressive diuresis can safely induce a weight loss of 0.5 to 1 kg daily with careful renal monitoring. Hold diuretics for electrolyte disturbance, azotemia, or induced encephalopathy.

Positive inotropic drugs and arterial vasodilators. These raise cardiac output and renal blood flow to reduce excess fluid. Nonselective beta-blockers lower portal pressure and are used for primary and secondary prophylaxis of variceal hemorrhage, partly by reducing intestinal permeability and inflammation in advanced disease.

V2 receptor antagonists. Vasopressin receptor antagonists raise free-water excretion, improve diuresis, and cut the need for paracentesis, though none is FDA-approved for ascites. Tolvaptan, an oral V2 antagonist, was FDA-approved in 2009 only for hyponatremia.

Cholestyramine. This anion exchange resin is the guideline-recommended first choice for pruritus in liver disease. Dose a 4-g sachet one hour before and after breakfast, and separate it from other medications by at least 4 hours to avoid interfering with their absorption.

Ursodeoxycholic acid (UDCA). UDCA is baseline therapy in several cholestatic conditions and improves overall survival. At 13 to 15 mg/kg/day it reduced itch intensity in women, with pruritus improving in 73% of women across a meta-analysis of 11 randomized controlled trials.

Rifampicin. Second-line for pruritus from liver disease. It has the strongest antipruritic effect on hepatic itch and can be used long-term, but monitor labs after 6 and 12 weeks because hepatotoxicity is a serious side effect.

Selective serotonin reuptake inhibitors (SSRIs). A fifth-line option. Sertraline showed a moderate itch-reducing effect in a placebo-controlled crossover trial; dose at 75 to 100 mg/day.

Topical antipruritics such as ammonium lactate cream. Mild itching may respond to topical ammonium lactate; the 12% lotion is indicated for temporary relief of itching associated with cirrhosis.

Supplemental vitamins (K, D, C); use caution with vitamin A and iron. These support prothrombin synthesis and coagulation when the liver functions. Vitamin C deficiency raises GI irritation and bleeding risk; vitamin K supports clotting. Vitamin A can be hepatotoxic, and iron is hard to process in high doses.

Stool softeners. These prevent straining, which raises intra-abdominal pressure and risks vascular rupture. Lactulose also moves ammonia from tissues into the gut.

Vasodilators. These treat variceal bleeding in the emergency department, lower portal pressure, and give the endoscopist a clearer view from less active bleeding.

Antifibrinolytics. Aminocaproic acid and tranexamic acid reduce hyperfibrinolysis short-term. Give aminocaproic acid 3 g four times daily by mouth until bleeding is controlled, or tranexamic acid 1 g IV every 6 hours. These are used mainly as rescue after procedures, rarely prophylactically.

Vasoconstrictors. Somatostatin and octreotide treat acute bleeding in portal hypertension before endoscopy. IV octreotide lowers portal pressure and can prevent rebleeding during the initial hospitalization.

Thrombopoietin agonists. Avatrombopag and lusutrombopag are oral TPO agonists, FDA-approved to raise platelet count before invasive procedures in chronic liver disease.

Cathartics. Lactulose and lactitol are non-absorbable disaccharides degraded by intestinal bacteria to lactic and other organic acids. Lactulose inhibits intestinal ammonia production and lowers colonic bacterial load.

Antibiotics. Neomycin, metronidazole, oral vancomycin, paromomycin, and oral quinolones lower colonic ammoniagenic bacteria. Neomycin is usually second-line after lactulose. Rifaximin, a nonabsorbable rifampin derivative, is as effective as lactulose or lactitol at improving encephalopathy.

L-ornithine L-aspartate (LOLA). Available in Europe but not the United States, LOLA is a stable salt of its two amino acids. L-ornithine stimulates the urea cycle, driving ammonia loss, and European trials found it effective for encephalopathy.

Zinc. Zinc improves hyperammonemia by raising ornithine transcarbamylase activity in the urea cycle, increasing ureagenesis and ammonia loss. Zinc sulfate and zinc acetate have been used at 600 mg orally daily in trials.

10. Monitoring Results of Diagnostic and Laboratory Procedures

Lab work includes liver function tests (ALT, AST, bilirubin, albumin, INR) to grade liver damage, plus complete blood count, renal function tests, viral hepatitis serology, and imaging such as ultrasound or CT to find causes and complications.

Serum glucose, prealbumin, albumin, total protein, prothrombin time (PT), and ammonia. Glucose may fall from impaired gluconeogenesis, depleted glycogen, or poor intake. Protein may be low from impaired metabolism, decreased hepatic synthesis, or peritoneal loss into ascites. Elevated ammonia may require protein restriction. PT rises from clotting factor defects and albumin falls as synthetic function drops, so serum albumin and PT are true indicators of synthetic hepatic function.

ABGs, pulse oximetry, vital capacity, and chest x-rays. These reveal respiratory deterioration. As a screen, pulse oximetry with a 96% saturation cutoff at room air is useful; SpO2 below 96% is highly sensitive and specific for HPS in patients with PaO2 below 70 mm Hg. HPS usually spares spirometry and lung volumes. On ABG, HPS hypoxemia grades as mild (PaO2 above 80 mm Hg), moderate (PaO2 60 to 79 mm Hg), severe (PaO2 50 to 59 mm Hg), and very severe (PaO2 below 50 mm Hg).

Renal function test. Hepatorenal syndrome is diagnosed with a creatinine clearance below 40 mL/minute, or a serum creatinine above 1.5 mg/dL with a urine volume below 500 mL/day and a urine sodium below 10 mEq/L. Urine osmolality exceeds plasma osmolality.

Contrast-enhanced echocardiography. Contrast echocardiography with agitated saline is the gold standard for diagnosing pulmonary vascular dilatation. Agitated normal saline generates microbubbles larger than 10 micrometers, injected into a peripheral arm vein during transthoracic echocardiography. Microbubbles appearing in the left atrium between the 4th and 6th cardiac cycle indicate pulmonary vasodilatation.